Free Access
Med Sci (Paris)
Volume 30, Novembre 2014
2e colloque de l’ITMO Santé publique – Médecine « personnalisée » et innovations biomédicales : enjeux de santé publique, économiques, éthiques et sociaux (Paris, 5 décembre 2013)
Page(s) 8 - 13
Section Session 1. Les grands enjeux de santé publique, économiques, éthiques et sociaux de la médecine personnalisée
Published online 17 November 2014
  1. President’s Council of Advisors on Science and Technology (PCAST) (2008). Priorities for personalized medicine. PCAST, September 2008 : 64 p. [Google Scholar]
  2. National Research Council of the National Academies. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Washington DC : The National Academic Press, 2011 : 128 p. [Google Scholar]
  3. European Science Foundation. Personalised medicine for the European citizen: towards more precise medicine for the diagnosis, treatment and prevention of disease (iPM). Strasbourg : European Science Foundation, October 2012 : 62 p. [Google Scholar]
  4. US Department of Health and Human Services, US Food and Drug Administration. Paving the way for personalised medicine: FDA’s role in a new era of product development. October 2013 : 62 p. [Google Scholar]
  5. The Academy of Medical Sciences. Realising the potential of stratified medicine. London, July 2013 : 102 p. [Google Scholar]
  6. Office parlementaire d’évaluation des choix scientifiques et technologiques (OPECST). Les progrès de la génétique, vers une médecine de précision ? Les enjeux scientifiques, technologiques, sociaux et éthiques de la médecine personnalisée. Alain Claeys et Jean-Sébastien Vialatte. Rapport n° 306 (2013–2014), 22 janvier 2014. [Google Scholar]
  7. Nuffield Council on Bioethics. Medical profiling and online medicine: the ethics of personalised health care in a consumer age. London : NCB, October 2010 : 250 p. [Google Scholar]
  8. European Science Foundation. ESF position paper: biobanks and sample repositories. Relevance to personalised medicine. Strasbourg : European Science Foundation, May 2011 : 8 p. [Google Scholar]
  9. Nuffield Council on Bioethics. Emerging biotechnologies: technology, choice and the public good. London : NCB, 2012 : 236 p. [Google Scholar]
  10. PHG Foundation. Public health in the era of genome based and personalised medicine. Cambridge : PHG Foundation, 2010 : 38 p. [Google Scholar]
  11. OECD. Public health in an age of genomics, OECD science, technology and industry policy papers, n° 8, OECD Publishing, 2013. [Google Scholar]
  12. Presidential Commission for the Study of Bioethical Issues. Privacy and progress in whole genome sequencing. Washington DC : Presidential Commission for the Study of Bioethical Issues, October 2012 : 150 p. [Google Scholar]
  13. President’s Commission for the Study of Bioethical Issues (PCSBI). Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. Washington DC : PCSBI, December 2013 : 156 p. [Google Scholar]
  14. Institute of Medicine of the National Academies (2014). Assessing genomic sequencing information for health care decision making. Workshop summary. Beachy SH, Johnson SG, Olson S, Berger AC (rapporteurs). Washington DC : National Academic Press, July 2014 : 124 p. [Google Scholar]
  15. Collins FS. Shattuck lecture: medical and societal consequences of the human genome project. N Engl J Med 1999 ; 341 : 28–37. [CrossRef] [PubMed] [Google Scholar]
  16. Guttmacher AE, Collins FS. Genomic medicine: a primer. N Engl J Med 2002 ; 347 : 1512–1520. [CrossRef] [PubMed] [Google Scholar]
  17. Feero WG, Guttmacher AE, Collins FS. Genomic medicine: an updated primer. N Engl J Med 2010 ; 362 : 2001–2011. [CrossRef] [PubMed] [Google Scholar]
  18. Gottesman O, Kuivaniemi H, Tromp G, et al. The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med 2013 ; 15 : 761–771. [CrossRef] [PubMed] [Google Scholar]
  19. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med 2000 ; 342 : 141–144. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.